Article info
PDFTherapeutics
Randomised controlled trial
In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality
- Correspondence to Sacha P Salzberg
Clinic for Cardiovascular Surgery, University Hospital, Raemistreet 100, Zurich 8091, Switzerland; sacha.salzberg{at}gmail.com
Citation
In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality
Publication history
- First published September 26, 2011.
Online issue publication
September 26, 2019
Article Versions
- Previous version (26 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions